Open Access License

Open Access License

TMP Universal Journal of Advances in Pharmaceutical Sciences follows an open-access publishing model, ensuring that all research articles published in the journal are freely available to the global research community and the general public. The Open Access License promotes the unrestricted use, distribution, and reproduction of published content, provided that proper attribution is given to the authors and the original publication.

  1. Creative Commons Attribution (CC BY) License
  • All articles published in TMP Universal Journal of Advances in Pharmaceutical Sciences are made available under the Creative Commons Attribution (CC BY) license.
  • Under this license, users are free to:
    • Copy, distribute, and transmit the work.
    • Adapt, remix, and build upon the work for commercial and non-commercial purposes.
    • Distribute derivative works under the same license as long as they properly attribute the original authors and the journal.
  1. Conditions of the Creative Commons Attribution (CC BY) License
  • Attribution: Users must provide appropriate credit to the original authors, the title of the article, the journal name, and a link to the license. Proper citation should be included when the work is reused or redistributed.
  • Non-Exclusive Rights: The CC BY license is non-exclusive, meaning authors retain the right to reuse their work, including in other publications or formats, as long as they credit the original publication in TMP Universal Journal of Advances in Pharmaceutical Sciences.
  • Permitted Use: Authors can upload their articles to institutional or subject-specific repositories, and users can incorporate the content into their own research, reports, teaching materials, and other educational or commercial uses.
  1. No Article Processing Charges (APC)
  • TMP Universal Journal of Advances in Pharmaceutical Sciences is fully open-access, with no Article Processing Charges (APC) for authors. This ensures that authors do not have to pay fees to make their work publicly available.
  • The journal promotes the free dissemination of scientific knowledge without any barriers for both authors and readers.
  1. Reuse and Remixing
  • Users may remix, adapt, and build upon the original work, including for commercial purposes, without asking for permission, provided that the original authors and the journal are credited.
  • This policy encourages collaboration, innovation, and the development of new research and knowledge based on previously published works.
  1. Long-Term Access and Preservation
  • Articles published under the Creative Commons Attribution (CC BY) license will remain accessible on the journal’s website and in external repositories, ensuring long-term access to the scholarly community and the public.
  • The journal commits to preserving all articles in multiple trusted digital archives, allowing for continued access even if changes occur in the journal’s hosting infrastructure.
  1. Ethical Use of Content
  • While the CC BY license permits a wide range of uses, users must still adhere to ethical standards, ensuring that the work is not used in a misleading context, misrepresented, or tampered with.
  • Content published under the CC BY license must not be used for illegal, defamatory, or unethical purposes.
  1. Support for Open Access Initiatives
  • TMP Universal Journal of Advances in Pharmaceutical Sciences fully supports open-access initiatives that promote the free exchange of scholarly work and the removal of access barriers for research.
  • The journal adheres to the principles of the Budapest Open Access Initiative (BOAI) and other global open-access frameworks that aim to accelerate the dissemination of academic knowledge for the benefit of society and the advancement of science.